Proposed M1 and M2 for Women`s Reproductive health

Transcription

Proposed M1 and M2 for Women`s Reproductive health
Proposed M1 and M2 for
Women’s Reproductive
health
Women’s Reproductive health
 M1 component shared time with Endocrinology
 Due to significant overlap between basic sciences base
for both disciplines.
 Covers 4 week interval January 19- Feb. 13
 M2 separately delivered.
 Covers 3 week interval Oct. 12-Oct. 30
 Sequenced prior to kidney and after endocrinology
M1
 Global objectives
 M1 consists of the basic science foundation (anatomy,
histology, pharmacology, embryology, genetics, and
physiology) followed by a clinical introduction to
Women’s Health preventative care, family planning and
prenatal care. This foundation will enable a sound
background in normal women’s reproductive health to
allow disease processes to be explored in M2 Women’s
Reproductive Health Issues. The M1 course will be
delivered in collaboration with endocrinology.
M1 WRH
 Longitudinal course goals:
 Aboriginal Women’s Health
 Domestic Violence
 Healthy Sexuality
 Sexual Assault
 Clinical reasoning -making sound contraceptive choices
 Ethics applied to Reproductive Health and endocrinology
cases

M1 WRH and endocrine
Global objectives

Describe the normal anatomy of the endocrine and female reproductive tract.

Describe the normal physiology of the endocrine and female reproductive system.

Describe the normal physiology and endocrinology of pregnancy.

Describe the histology of the endocrine and reproductive system.

Describe the chemistry of reproductive hormones and their control of reproduction.

Describe the changes in female reproductive cycle related to puberty, menstruation, contraception and
menopause.

State the basic principles of pharmacology as applied to drugs used in endocrinology, women’s
reproductive health care and pregnancy.

Describe the normal embryologic development of the endocrine and women’s reproductive tract
systems.

Explain the physiology of pregnancy with regard to placental transfer, fetal oxygenation, maternal acid
base balance, fetal lung maturation, major system changes in the mother, and lactation
 M1 schedule as per hand out available in final excel
document
M2 WRH Global Objectives
 Describe the normal life cycle of the reproductive tract.
 Classify, diagnose and treat benign changes from normal in the vulva, vagina,
cervix, endometrium, body of the uterus, fallopian tubes, and breast.
 Classify, diagnose and treat pre-malignant and malignant changes from
normal in the vulva, vagina, cervix, endometrium, body of the uterus, fallopian
tubes and breast.
 Identify pathogens commonly encountered in female genital tract and the
prevention and treatment of infections caused by these agents.
 Discuss care management in the intrapartum and postpartum period.
 Recall assessment of neonatal well being.
M2 WRH Global Objectives

Discuss complications of pregnancy, and early pregnancy loss including risk factors prevention,
screening diagnosis, management and prognosis.

Discuss the epidemiology, prevention, screening, diagnosis, management and management of
complications of treatment, and prognosis of common general gynecologic problems related to
congenital, inflammatory or neoplastic lesions, urogynecologic problems, perimenopausal disorders,
abnormal uterine bleeding, endometriosis and adenomyosis, the climacteric, pediatric and adolescent
gynecology and sexually transmitted diseases.

Discuss the epidemiology, prevention, screening, diagnosis and management of perinatal infections,
including HIV, syphilis, rubella and other viral infections.

Apply knowledge of gynecologic endocrinology to differentiate normal from amenorrhea and
dysfunctional uterine bleeding, normal pubertal development from abnormalities.

Outline the common surgical procedures employed in gynecology including indications, complications
and prognosis.

Outline the common benign diseases of the breast and their treatment, outline screening programs for
Breast cancer, outline epidemiology, diagnosis and treatment for breast cancer.
Longitudinal presentations

Domestic violence and sexual assault have been removed due to time constraints these will need to
be covered in longitudinal courses. M1 or 2

Chronic pelvic pain has also been removed this could be accommodated in composite clinical
presentations M2 and clinical reasoning

Family planning and incontinence should also be revisited in composite clinical presentations, also
amenorrhea and abnormal uterine bleeding. M1, M2 and clinical reasoning

Pregnancy should be revisited in the longitudinal course, social determinants of health are very
important for access to quality prenatal care. M1 and M2

A longitudinal element that would be a good fit with this curriculum in the week where obs is discussed
would be fetal alcohol syndrome and addiction disorders during pregnancy, newborn outcomes and
care. Do not have enough time in the base curriculum to do this. M1

Genetics needs additional coverage longitudinal courses M1and in M2 related to cancer risk and
genetics

Revisit hematologic, diabetic and hypertensive disorders in M2 related to pregnancy

Social determinants of health related to cancer screening and prevention in M2